Tolvaptan for the treatment of heart failure: a review of the literature
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.2011.567267
Reference73 articles.
1. Heart Disease and Stroke Statistics—2010 Update
2. The current and future management of acute heart failure syndromes
3. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure
4. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects
5. Vasopressin: a new target for the treatment of heart failure
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of Low-Dose Tolvaptan for Fluid Management After Cardiovascular Surgery;Circulation Reports;2022-12-09
2. Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial;Clinical and Experimental Nephrology;2022-04-26
3. Characterization of tolvaptan response and its impact on the outcome for patients with heart failure;Journal of Cardiology;2021-10
4. Effect of oral tolvaptan for 1 year in patients with functional mitral regurgitation;Heart and Vessels;2021-09-02
5. Tolvaptan can limit postoperative paroxysmal atrial fibrillation occurrence after open-heart surgery;Surgery Today;2020-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3